Sagimet Biosciences Inc. (SGMT) Operating cash flow 2022–2025
Sagimet Biosciences Inc. (SGMT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$45.6MFY2025 · since FY2022: -$24.5M → -$45.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.6M | -7.6% |
| FY2024 | -$42.4M | -78.6% |
| FY2023 | -$23.8M | +3.0% |
| FY2022 | -$24.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice